Neutra Corp

What Neutra Corp does

Neutra Corp (OTC: NTRR) is a publicly traded holding company headquartered in Houston, Texas (2500 CityWest Blvd, Ste 150-161), originally incorporated in 2011 as a research and development company in nutraceuticals, food and drug, and environmental purification markets. In 2025 the company executed a strategic pivot, launching wholly owned subsidiary Neutra Life Sciences—a Site Management Organization (SMO) that oversees clinical research sites across multiple therapeutic areas including Oncology, Dermatology, Pulmonology, and Women's Health. The SMO integrates proprietary Standard Operating Procedures with industry best practices to manage trial operations, patient experiences, and data delivery, and is delivered through a network of joint-venture research sites established with healthcare providers (e.g., Women's Healthcare Center of Baytown for women's health/OB-GYN research).

Revenue is generated primarily through contract-based clinical research services with pharmaceutical/biotech sponsors and Contract Research Organizations (CROs). The GTM model combines enterprise field sales to sponsors and CROs with a joint-venture site-buildout strategy. The January 2026 partnership with major CRO Parexel is the company's most prominent commercial relationship and is cited by management as the primary driver behind the projected 1,000% year-over-year revenue increase. Marketing and investor communications rely on press release distribution, an investor relations website, OTC Markets filings, and conference attendance (SCRS Global Site Solutions Summit, Obesity Week 2026). Additional growth vectors include a Letter of Intent to acquire CuraConnector.com, Inc. (April 2025) in healthcare information/digital technology, and ongoing site-network JV expansion. A July 2026 Securities Purchase Agreement Reversal and Debt Settlement with VIVIS Corporation indicates active balance-sheet management to redirect resources to the SMO subsidiary.

Name

Neutra Corp

Legal name

Neutra Corp

Website

https://neutrainc.com

Company type

Public

Founded year

2011

Operating status

Operating

Headcount range

1–10 employees

Short description

Neutra Corp is a Houston-based public holding company (OTC: NTRR) that operates a Site Management Organization—subsidiary Neutra Life Sciences—running multi-therapeutic clinical research sites for pharmaceutical sponsors and CROs, including a flagship partnership with Parexel.

Ownership category

akta.pro rank

Product category

Clinical Research Services (Site Management Organization)

NAICS

Scientific Research and Development Services (5417), Other Scientific and Technical Consulting Services (54169), Management Consulting Services (54161)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Management Services (8741)

akta.pro primary industry

Clinical Trial Site Operations & Study Coordination (HLAGACAE)

akta.pro secondary industries

Site Identification & Feasibility (HLAGACAB), Site Quality Management & Audit Readiness (HLAGACAN), Clinical Quality Assurance (GCP QA, TMF/QMS oversight) (HLAGAKAI)

Keywords

• Clinical research services
• Site management organization
• Clinical trial management
• Life sciences operations
• Research site network

Headquarters

HQ city

Katy

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Clinical Research Contract Services: Neutra Life Sciences generates revenue through contract-based clinical research services. The subsidiary receives awards for clinical trials across multiple therapeutic areas (Oncology, Dermatology, Pulmonology, Women's Health) and signs contracts with sponsors and CROs. The company projects significant revenue growth driven by its expanding trial portfolio and multi-site network.
2. Joint Venture Research Sites: Revenue is generated through joint venture partnerships with healthcare providers like Women's Healthcare Center of Baytown, where Neutra Life Sciences establishes dedicated research sites focused on specific therapeutic areas, generating additional revenue streams through contract-based research.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels4 records

Core offering

Neutra Corp, through its wholly owned subsidiary Neutra Life Sciences, operates a Site Management Organization (SMO) that oversees multiple clinical research sites across therapeutic areas including Oncology, Dermatology, Pulmonology, and Women's Health. The company delivers contract-based clinical trial management and execution services to pharmaceutical/biotech sponsors and Contract Research Organizations (CROs), integrating proprietary Standard Operating Procedures with industry best practices to optimize trial operations, patient experiences, and data quality.

Product overview

Neutra Corp operates as a life sciences and healthcare technology company with a diversified portfolio centered on life sciences technology and Site Management Organization (SMO) operations. The company's primary offering is its wholly owned subsidiary Neutra Life Sciences, which functions as a comprehensive SMO managing clinical research sites across various specialties including oncology, dermatology, pulmonology, and women's health. The subsidiary integrates proprietary Standard Operating Procedures (SOPs) with industry best practices to optimize trial operations, enhance patient experiences, and deliver high-quality clinical data.

Differentiator

Problem solved

Functional benefit

Brands

• Neutra Life Sciences: Clinical research site management organization (SMO) comprised of multiple clinical research sites across various specialties, dedicated to transforming clinical research through a patient-centric approach.

Products and services

• Neutra Life Sciences Site Management Organization (SMO) Services
• Specialty Clinical Research Site Operations (Women's Health / OB-GYN)

Quantifiable outcome

• Projected over 1,000% revenue increase year-over-year

Named customers2 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

Two partnerships are on record, tiered core.

• Women's Healthcare Center of BaytowncoreStrategic or Co-development Partner · 29 June 2026Neutra Life Sciences formed a joint venture with Women's Healthcare Center of Baytown to open a research site focused on women's health and OB/GYN specialties in Baytown, Texas. The joint venture establishes a dedicated women's health research site as part of the expanding clinical trial network.
• ParexelcoreStrategic or Co-development Partner · 19 January 2026Neutra Corp partnered with Parexel, a leading CRO, to enhance its clinical trial capabilities. This partnership is credited as a key driver of the company's projected 1,000% revenue increase and represents a significant strategic relationship with a major CRO player.

Scale indicators3 records

Recent moves9 records

Expansion highlights6 records

Direct peers

• Sarah Cannon Research Institute: Sarah Cannon is a leading oncology-focused Site Management Organization running community-based clinical trials across the US. It is comparable to Neutra Life Sciences in oncology-specific site management and shares the multi-site JV-style operating model.
• Velocity Clinical Research: Velocity Clinical Research is a multi-therapeutic Site Management Organization operating integrated research sites across the United States. It is the closest direct peer to Neutra Life Sciences, competing head-to-head for sponsor and CRO trial placement across similar therapeutic areas.
• DM Clinical Research: DM Clinical Research operates a multi-site clinical research network in Texas and surrounding states, focused on multi-therapeutic trial execution. It directly competes with Neutra Life Sciences for trial placement in the same regional footprint and therapeutic areas.

Broad incumbents

• IQVIA: IQVIA is the largest global CRO with a substantial site management and clinical operations footprint, including its Patient Recruitment Site Network and integrated clinical delivery platform. It competes with Neutra Life Sciences for trial placement and represents the upper bound of scale and capability in this space.
• Medpace: Medpace is a mid-to-large CRO with strong site-management operations focused on Phase II–IV trials across multiple therapeutic areas. It competes with Neutra Life Sciences for sponsor awards and operates a similar trial-execution model.
• ICON plc: ICON is a top-tier global CRO with site management, decentralized trial, and patient-recruitment capabilities following its PRA Health Sciences acquisition. It overlaps with Neutra Life Sciences on multi-TA trial execution and SMO services to sponsors.
• WCG (WIRB-Copernicus Group): WCG provides site-focused services including IRB review, IBC review, and clinical technology that supports site operations across the industry. It is adjacent to Neutra Life Sciences' SMO operations and overlaps in serving the same clinical research site customer base.
• Syneos Health: Syneos Health is a fully integrated biopharmaceutical solutions organization offering both CRO and commercial services, including site management and patient recruitment. It is broadly comparable to Neutra Life Sciences in multi-TA trial execution and site-network services.

Emerging players

• Florence Healthcare: Florence Healthcare provides site-focused clinical trial technology (eTMF, eRegulatory) that supports site operations across the research industry. It is adjacent to Neutra Life Sciences in serving the same site-network customer base and addressing site-management inefficiencies.
• Clinipace Worldwide: Clinipace is a mid-sized CRO with site management and biometrics capabilities serving small-to-mid biopharma sponsors. Comparable to Neutra Life Sciences in competing for trial awards from emerging biopharma sponsors with similar multi-TA focus.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/CorpNeutra
• Facebookfacebook.com/neutracorp
• LinkedInlinkedin.com/company/neutra-corp

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Neutra Corp